Floatz logo

Immunoglobulin G1-lambda7, anti-[Homo sapiens tumor-restricted extracellular ribonucleoprotein (RNP) complex containing PABPC1 (polyadenylate-binding protein cytoplasmic 1, PABP1)bound to poly(A)RNA], Homo sapiens monoclonal antibody

Acral Lentiginous Melanoma

Atreca, Inc.monoclonal_antibodyPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

19 Active assets in the Acral Lentiginous Melanoma cohort.

Asset / SponsorPhaseRating
Pembrolizumab
Yonsei University
Phase 2BB
Nilotinib
Institute of Cancer Research, United Kingdom
Phase 2B
Rivoceranib
Peking University Cancer Hospital & Institute
Phase 3B
Nivolumab
Fred Hutchinson Cancer Center
Phase 2B
Imatinib
National Cancer Institute (NCI)
Phase 2B

View all 29 →

Same molecule, other indications

Immunoglobulin G1-lambda7, anti-[Homo sapiens tumor-restricted extracellular ribonucleoprotein (RNP) complex containing PABPC1 (polyadenylate-binding protein cytoplasmic 1, PABP1)bound to poly(A)RNA], Homo sapiens monoclonal antibody is also rated in:

primary peritoneal carcinomaDormant
CC
Indicative ·
43 / 100
View asset →
fallopian tube carcinomaDormant
CC
Indicative ·
43 / 100
View asset →
ovarian carcinomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →